Rapid Diagnostic Tests (RDTs) Reshape India’s Malaria Detection Landscape

The India malaria diagnostics market is on a promising growth trajectory, with projections indicating a climb from USD 61.6 million in 2025 to USD 81.6 million by 2032. This signifies a compound annual growth rate (CAGR) of approximately 4.1% during the forecast period, according to the latest industry analysis.

Behind this growth lies a robust framework of strategic alliances between the Indian government, global health organizations, and private healthcare enterprises. As India intensifies efforts to eliminate malaria, the rising demand for efficient and affordable diagnostic solutions is spurring innovations and partnerships across the healthcare ecosystem.

Government-Led Momentum: Driving Market Accessibility

At the heart of this transformation is the National Strategic Plan for Malaria Elimination (2017–2022), now extended and restructured for long-term impact. This flagship initiative by the Ministry of Health and Family Welfare focuses on achieving a malaria-free India by 2030. By prioritizing early detection and timely treatment, the program is enhancing accessibility to diagnostics in remote and high-risk regions.

State and district-level health departments are also playing a critical role by conducting mass screenings, especially in endemic zones like Odisha, Chhattisgarh, and parts of the Northeast. These campaigns rely heavily on rapid diagnostic tests (RDTs), which are now being distributed at scale, thanks to government bulk procurements and public-private contracts.

“The Indian government has significantly improved its procurement and distribution logistics for malaria test kits. This has brought affordable diagnostics to the most underserved communities,” noted Dr. N. L. Singh, an infectious disease specialist based in Lucknow.

Rise of Rapid Diagnostic Tests (RDTs) and Point-of-Care Solutions

Among the most transformative trends in the market is the rising adoption of rapid diagnostic tests, which allow for quick, on-site diagnosis without the need for advanced laboratory infrastructure. RDTs now account for a substantial share of the diagnostics market, especially in rural and tribal areas where laboratory access remains limited.

The World Health Organization (WHO) and The Global Fund to Fight AIDS, Tuberculosis and Malaria have been instrumental in supporting India’s transition to RDT-based screening. Their financial grants and technical training programs have enabled frontline health workers to accurately identify Plasmodium falciparum and Plasmodium vivax, the two most prevalent malaria parasites in India.

“Point-of-care testing has revolutionized the way we approach malaria diagnosis in the field,” said Dr. Reema Banerjee, who oversees a mobile diagnostic unit in Jharkhand. “We’re now able to confirm and start treatment within minutes, which saves lives and prevents transmission.”

Private Sector Innovation and Accessibility

While public health initiatives have laid the foundation, the private sector is injecting innovation and efficiency into the market. Domestic diagnostic companies such as Mylab Discovery Solutions, J Mitra & Co., and Agappe Diagnostics are developing cost-effective kits tailored to India’s unique epidemiological landscape. These companies are focusing on high sensitivity, ease of use, and heat-stability—key factors for operations in India’s diverse climate conditions.

In addition, multinational companies like Abbott, Bio-Rad Laboratories, and Access Bio are expanding their footprint in India through strategic partnerships and localized manufacturing. These collaborations are helping reduce costs and ensure consistent supply chains for diagnostics.

The COVID-19 pandemic has also accelerated digital health adoption, with several companies now offering telemedicine-integrated diagnostic services. This model supports remote consultations, home sample collection, and even doorstep delivery of rapid test kits.

Expanding Laboratory Infrastructure and Skilled Workforce

India's efforts to combat malaria are also supported by the expansion of laboratory infrastructure under public health missions such as the Ayushman Bharat initiative. Government investment in primary health centers (PHCs) and community health centers (CHCs) has increased the number of facilities capable of conducting microscopy-based diagnostics, the gold standard for malaria confirmation.

Moreover, the government, in collaboration with WHO and other development partners, is training health workers to enhance diagnostic accuracy and prevent false positives/negatives. Through initiatives like Integrated Disease Surveillance Programme (IDSP), laboratory technicians across India are being upskilled to ensure quality-assured malaria testing.

“Proper training is critical to avoid misdiagnosis, especially when malaria symptoms overlap with other febrile illnesses like dengue or typhoid,” emphasized Dr. Arvind Patel, Director of Public Health in Gujarat. “We are focusing heavily on certification and monitoring systems for lab personnel.”

Regional Trends and Disease Burden

Geographically, India’s malaria diagnostics market is segmented into four primary regions: North, South, East, and West India. The Eastern region, particularly Odisha, Jharkhand, and West Bengal, contributes a significant share to the market due to its high malaria burden.

According to the latest National Center for Vector Borne Disease Control (NCVBDC) data, Odisha alone accounts for over 30% of India's malaria cases, making it a critical focus for diagnostics deployment.

Conversely, Southern states like Kerala and Tamil Nadu, which have made strides in malaria control, are now emerging as testing hubs for clinical trials and next-generation diagnostics, such as molecular testing and AI-based predictive tools.

Challenges Remain: Funding, Counterfeit Kits, and Climate Factors

Despite significant progress, several challenges could hinder the market's growth. Underfunding, especially at the district level, continues to affect surveillance and diagnostics in remote regions. Additionally, the market is occasionally disrupted by the influx of substandard or counterfeit diagnostic kits, which compromise both accuracy and patient trust.

Climate change is another emerging concern. Rising temperatures and erratic rainfall are altering vector behavior, potentially expanding the malaria transmission window and complicating disease surveillance. This dynamic scenario underscores the importance of robust, adaptable diagnostic systems that can respond quickly to new hotspots.

Outlook: Technological Advancements and Policy Focus to Sustain Momentum

Looking ahead, technological innovations such as CRISPR-based diagnostics, AI-powered diagnostic algorithms, and mobile health (mHealth) platforms are poised to redefine the landscape. Companies and research institutions are exploring multi-pathogen test kits that can simultaneously detect malaria and other febrile diseases, enhancing diagnostic efficiency.

Government initiatives under the Digital Health Mission, as well as the inclusion of malaria diagnostics under universal health coverage, are expected to provide further momentum to the market. Regulatory support from bodies like the Central Drugs Standard Control Organization (CDSCO) will be vital in fast-tracking approvals for next-generation diagnostic tools.

“Innovation, affordability, and scale—India has all the elements necessary to become a global leader in malaria diagnostics,” said Rajiv Mehta, CEO of a leading biotech firm. “The next few years will be crucial in shaping not just market numbers, but also health outcomes.”

Conclusion

With a well-orchestrated synergy between public health policy, private sector capabilities, and international support, the India malaria diagnostics market is poised for steady growth and strategic transformation. As the country edges closer to its malaria elimination goal, the emphasis on early, accurate, and widespread diagnostic access will remain the cornerstone of its success.

By 2032, as the market is expected to reach USD 81.6 million, India’s model could well serve as a blueprint for malaria control efforts in other developing nations grappling with similar challenges.